Toho Holdings Co., Ltd.

8129.T
Medical Distribution
2026/11/20 13:29 Updated
Market Cap: $1.6B (¥259.0B)
Stock Price: $24.96 (¥3,962)
Exchange Rate: 1 USD = ¥158.73

Stock Price Chart

2026/11/20 13:29 Updated
17.07
PER (Price Earnings Ratio)
vs Industry Avg: +7.5
0.96
PBR (Price to Book Ratio)
vs Industry Avg: -0.3
4.55%
Dividend Yield
vs Industry Avg: +1.60%

Price Trend

2026/11/20 13:29 Updated
Short-term
5-Day MA
-0.43%
Near-term
25-Day MA
-0.38%
Mid-term
75-Day MA
+2.10%
Long-term
200-Day MA
-3.69%

Price & Trading Details

2026/11/20 13:29 Updated

PRICE

Previous Close ¥3,995
Open ¥3,952
High ¥4,020
Low ¥3,952
Close ¥3,962

TRADING

Volume 46,600
Average Volume 152,701
Turnover ¥2億
Min. Purchase ¥396,200

Analyst Recommendations 2 analysts

Updated 2026/11/01
Strong Buy
0
Buy
0
Hold
2
2
Sell
0
Strong Sell
0
Target Price (Mean)
¥4,050
None
¥4,600
High
¥4,050
Median
¥3,500
Low
-13% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/11/01
NOV
11
2026
Next Earnings Release
Q4 FY2026

Recent Earnings

Date EPS Est. EPS Actual Surprise
2026/05/13 ¥66.21 ¥44.13 -33.4%
2026/02/11 ¥117.06 ¥127.93 +9.3%
2025/08/05 ¥28.82 ¥53.61 +86.0%

Shareholder Composition

Updated 2026/11/01
11.8%
Insider Holdings
38.3%
Institutional
49.9%
Public Float
80
Institutional Holders
Insider Holdings 11.8%
Institutional 38.3%
Public Float 49.9%

Dividend History 3Years Growth

Updated 2026/11/22
-%
Dividend Yield
¥90
Annual Dividend
+153.8%
YoY Growth
34.5%
Payout Ratio
Year Dividend Change
2027 In Progress ¥90 -
2026 ¥165 +153.8%
2025 ¥65 +62.5%
2024 ¥40 +25.0%
2023 ¥32 -

Financial Performance

2026/11/22 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥1,266,171M ¥1,392,117M ¥1,476,712M ¥1,518,495M
Gross Profit ¥108,687M ¥114,366M ¥119,148M ¥121,648M
Operating Income ¥12,534M ¥16,369M ¥19,337M ¥18,942M
Pretax Income ¥20,186M ¥20,492M ¥30,845M ¥28,102M
Net Income ¥13,379M ¥13,630M ¥20,657M ¥19,844M
EPS ¥174.48 ¥180.67 ¥286.79 ¥284.22
Operating Margin 0.99% 1.18% 1.31% 1.25%
Balance Sheet
Total Assets ¥702,376M ¥715,288M ¥773,427M ¥722,805M
Total Equity ¥241,079M ¥242,823M ¥249,330M ¥256,779M
Total Liabilities ¥461,297M ¥472,465M ¥524,097M ¥466,026M
Cash ¥94,256M ¥86,201M ¥132,970M ¥86,533M
Interest-bearing Debt ¥40,737M ¥37,888M ¥30,244M ¥21,260M
Equity Ratio 34.32% 33.95% 32.24% 35.53%
D/E Ratio 0.17 0.16 0.12 0.08
Cash Flow
Operating CF ¥16,341M -¥9M ¥59,934M -¥26,675M
Investing CF -¥11,032M ¥4,315M ¥9,091M -¥4,180M
Financing CF -¥4,473M -¥13,060M -¥22,195M -¥20,364M
Free CF ¥12,139M -¥2,528M ¥56,153M -¥32,432M
Efficiency
ROE 5.55% 5.61% 8.29% 7.73%
ROA 1.90% 1.91% 2.67% 2.75%

Latest IR Information

Company Information

English Name Toho Holdings Co., Ltd.
Japanese Name 東邦ホールディングス(株)
Stock Code 8129.T (JPX)
Sector / Industry Healthcare / Medical Distribution
Employees 7,675

About

Toho Holdings Co., Ltd., together with its subsidiaries, engages in the wholesale distribution of pharmaceutical products in Japan. It operates in four segments: Pharmaceutical Wholesaling Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. The company distributes pharmaceuticals, narcotics, reagents, medical equipment and devices, medical materials, and over-the-counter products to hospitals, clinics, and dispensing pharmacies. It also provides customer support systems for patients and medical institutions comprising Future ENIF, an information terminal for pharmaceutical ordering; LXMATE HeLios Cloud, a medical care appointment system; and MIZAR, a centralized administration system of pharmacy operations, as well as L1MON, a patient home delivery service for specialty products. In addition, the company engages in the management of the dispensing pharmacies and health insurance dispensing pharmacies; provision of support home medical care and data processing services; and real estate agency business. Further, it provides generic and injection drugs on consignment; contract manufacturing of ampoule and vial formulations; and contract testing for pharmaceutical quality control and stability testing. Additionally, the company engages in site management organization; planning and sale of information processing equipment; software development and sales; corporate and medical management and consulting; internet business related to pharmaceuticals; general motor truck transportation; cashless payment and factoring; remote detailing; and manufacture and sale of hygienic materials. The company was formerly known as Toho Pharmaceutical Co., Ltd. and changed its name to Toho Holdings Co., Ltd. in April 2009. Toho Holdings Co., Ltd. was incorporated in 1948 and is headquartered in Chuo, Japan.

Data provided by Yahoo Finance